Shortening Timelines to Phase I Formulation

With micro-dosing technology, the number of process steps involved in taking a new drug into clinical trials can be reduced, enabling new drugs to enter the clinic more quickly and failed compounds to be weeded out earlier - resulting in valuable savings in clinical expenditure.

By David Edwards at Capsugel (March 2009)

Keywords: Drivers in critical path, automated micro-dosing, process development.

View full article    |    Back to Ingredients, Formulations and Finishing section